SCHEMBL5879415

SCHEMBL5879415

O=c1oc(=O)c2c1c1[nH]c3ccccc3c1c1c(=O)[nH]c(=O)c21

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 6/20 0.75
CDK5 Q00535 5/20 0.49
CDK5R1 Q15078 4/20 0.49
DYRK1A Q13627 2/20 0.49
GSK3A P49840 2/20 0.48
GSK3B P49841 2/20 0.48
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
PRKCA P17252 3/20 0.46
MAPT P10636 3/20 0.46
CDK4 P11802 2/20 0.46
CCND1 P24385 2/20 0.46
PRKD3 O94806 1/20 0.46
CCNB2 O95067 1/20 0.46
CCNE2 O96020 1/20 0.46
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
PRKACA P17612 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bis-Imide A SCHEMBL5879127 0.86 CHEK1 (1.00) CHEK1CDK5CDK5R1GSK3AGSK3B
Bis-Imide A SCHEMBL31061368 0.86 CHEK1 (1.00) CHEK1CDK5CDK5R1GSK3AGSK3B
SCHEMBL5879218 0.82 CHEK1 (0.50) CHEK1CDK5CDK5R1DYRK1AGSK3A
SCHEMBL5879196 0.79 CHEK1 (0.50) CHEK1CDK5CDK5R1DYRK1AGSK3A
SCHEMBL23132393 0.76 CHEK1 (0.73) CHEK1CDK5CDK5R1DYRK1AGSK3A
SCHEMBL5879158 0.75 CHEK1 (0.71) CHEK1CDK5CDK5R1GSK3AGSK3B
SCHEMBL5879135 0.75 CHEK1 (0.76) CHEK1CDK5CDK5R1GSK3AGSK3B
SCHEMBL23132413 0.74 CHEK1 (0.76) CHEK1CDK5CDK5R1GSK3AGSK3B
SCHEMBL2956909 0.73 CHEK1 (0.69) CHEK1CDK5CDK5R1GSK3AGSK3B
SCHEMBL5339297 0.73 CHEK1 (0.57) CHEK1CDK5CDK5R1DYRK1AGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7151108-B2 Anticarcinogenic, antiproliferative, and antitumor agents LES LABORATORIES SERVIER (FR) 2006-12-19 US disclosed
EP-1411057-B1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-04-27 EP disclosed
EP-1411057-A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2004-04-21 EP disclosed